{"entity":{"type":"insider","cik":"0001743927","url":"/insider/0001743927","json_url":"/insider/0001743927.json","name":"Liawatidewi Yakob","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":23,"first":"2018-11-13","last":"2024-11-08","span_basis":"filed_date"},"name_variants":[{"name":"Liawatidewi Yakob","source":"filing","n_filings":23,"first_seen":"2018-11-13","last_seen":"2024-11-08"}],"transactions":[{"id":2864200,"accession":"0001415889-24-026480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-026480","line_url":"/filing/0001415889-24-026480#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Director, Officer (EVP CORP ADMIN CENTER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP CORP ADMIN CENTER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5214.0,"shares_display":"5,214","price_per_share":52.05,"price_display":"52.05","price_state":"stated","total_value":271388.7,"total_display":"271,388.70","total_whole":"271,389","shares_owned_after":74938.0,"shares_owned_after_display":"74,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-08","scope":"insider"},{"id":8673697,"accession":"0001104659-23-096618","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-096618","line_url":"/filing/0001104659-23-096618#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Director, Officer (EVP Corp Admin Center)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28816.0,"shares_display":"28,816","price_per_share":53.13,"price_display":"53.13","price_state":"stated","total_value":1530994.08,"total_display":"1,530,994.08","total_whole":"1,530,994","shares_owned_after":69669.0,"shares_owned_after_display":"69,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-28","filed_date":"2023-08-29","scope":"insider"},{"id":8673417,"accession":"0001104659-23-045715","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-045715","line_url":"/filing/0001104659-23-045715","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Director, Officer (EVP Corp Admin Center)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11494.0,"shares_display":"11,494","price_per_share":41.564990429789454,"price_display":"41.56","price_state":"stated","total_value":477748.0,"total_display":"477,748.00","total_whole":"477,748","shares_owned_after":69215.0,"shares_owned_after_display":"69,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-14","scope":"insider","n_lines":2},{"id":7803664,"accession":"0001104659-23-044692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-044692","line_url":"/filing/0001104659-23-044692#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Director, Officer (EVP Corp Admin Center)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":69215.0,"shares_owned_after_display":"69,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-12","scope":"insider"},{"id":6927861,"accession":"0001104659-22-088691","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-088691","line_url":"/filing/0001104659-22-088691#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3055.0,"shares_display":"3,055","price_per_share":39.0,"price_display":"39.00","price_state":"stated","total_value":119145.0,"total_display":"119,145.00","total_whole":"119,145","shares_owned_after":61607.0,"shares_owned_after_display":"61,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-10","scope":"insider"},{"id":6927855,"accession":"0001104659-22-088691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-088691","line_url":"/filing/0001104659-22-088691#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":190000.0,"total_display":"190,000.00","total_whole":"190,000","shares_owned_after":61607.0,"shares_owned_after_display":"61,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6267668,"accession":"0001104659-22-080589","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-080589","line_url":"/filing/0001104659-22-080589","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10837.0,"shares_display":"10,837","price_per_share":36.64141478268893,"price_display":"36.64","price_state":"stated","total_value":397083.012,"total_display":"397,083.01","total_whole":"397,083","shares_owned_after":61607.0,"shares_owned_after_display":"61,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-18","scope":"insider","n_lines":2},{"id":4282351,"accession":"0001104659-21-099442","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-099442","line_url":"/filing/0001104659-21-099442#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8932.0,"shares_display":"8,932","price_per_share":21.138,"price_display":"21.14","price_state":"stated","total_value":188804.616,"total_display":"188,804.62","total_whole":"188,805","shares_owned_after":54077.0,"shares_owned_after_display":"54,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-03","scope":"insider"},{"id":5282303,"accession":"0001104659-21-093170","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-093170","line_url":"/filing/0001104659-21-093170#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31524.0,"shares_display":"31,524","price_per_share":20.0066,"price_display":"20.01","price_state":"stated","total_value":630688.0584,"total_display":"630,688.06","total_whole":"630,688","shares_owned_after":54077.0,"shares_owned_after_display":"54,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-16","scope":"insider"},{"id":5403946,"accession":"0001104659-21-068827","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-068827","line_url":"/filing/0001104659-21-068827#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9637.0,"shares_display":"9,637","price_per_share":19.9944,"price_display":"19.99","price_state":"stated","total_value":192686.0328,"total_display":"192,686.03","total_whole":"192,686","shares_owned_after":53573.0,"shares_owned_after_display":"53,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-18","scope":"insider"},{"id":5403940,"accession":"0001104659-21-068827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-068827","line_url":"/filing/0001104659-21-068827#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3186.0,"shares_display":"3,186","price_per_share":19.9164,"price_display":"19.92","price_state":"stated","total_value":63453.6504,"total_display":"63,453.65","total_whole":"63,454","shares_owned_after":53573.0,"shares_owned_after_display":"53,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":5051102,"accession":"0001104659-21-066127","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-066127","line_url":"/filing/0001104659-21-066127#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4592.0,"shares_display":"4,592","price_per_share":19.3254,"price_display":"19.33","price_state":"stated","total_value":88742.2368,"total_display":"88,742.24","total_whole":"88,742","shares_owned_after":56759.0,"shares_owned_after_display":"56,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":5051094,"accession":"0001104659-21-066127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-066127","line_url":"/filing/0001104659-21-066127#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.0597,"price_display":"19.06","price_state":"stated","total_value":190597.0,"total_display":"190,597.00","total_whole":"190,597","shares_owned_after":61351.0,"shares_owned_after_display":"61,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":2968722,"accession":"0001104659-20-085726","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-085726","line_url":"/filing/0001104659-20-085726#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5978.0,"shares_display":"5,978","price_per_share":21.2173,"price_display":"21.22","price_state":"stated","total_value":126837.0194,"total_display":"126,837.02","total_whole":"126,837","shares_owned_after":45996.0,"shares_owned_after_display":"45,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-22","scope":"insider"},{"id":2968716,"accession":"0001104659-20-085726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-085726","line_url":"/filing/0001104659-20-085726#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4186.0,"shares_display":"4,186","price_per_share":21.0336,"price_display":"21.03","price_state":"stated","total_value":88046.6496,"total_display":"88,046.65","total_whole":"88,047","shares_owned_after":45996.0,"shares_owned_after_display":"45,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":3043224,"accession":"0001104659-20-072124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-072124","line_url":"/filing/0001104659-20-072124#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (EVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (EVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23405.0,"shares_display":"23,405","price_per_share":20.406,"price_display":"20.41","price_state":"stated","total_value":477602.43,"total_display":"477,602.43","total_whole":"477,602","shares_owned_after":46124.0,"shares_owned_after_display":"46,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider"},{"id":8614089,"accession":"0001104659-19-050441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-050441","line_url":"/filing/0001104659-19-050441#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":21.4467,"price_display":"21.45","price_state":"stated","total_value":64340.1,"total_display":"64,340.10","total_whole":"64,340","shares_owned_after":33670.0,"shares_owned_after_display":"33,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-17","scope":"insider"},{"id":7995736,"accession":"0001104659-19-049385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-049385","line_url":"/filing/0001104659-19-049385#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2395.0,"shares_display":"2,395","price_per_share":21.9018,"price_display":"21.90","price_state":"stated","total_value":52454.811,"total_display":"52,454.81","total_whole":"52,455","shares_owned_after":2459.0,"shares_owned_after_display":"2,459","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-09","scope":"insider"},{"id":7995730,"accession":"0001104659-19-049385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-049385","line_url":"/filing/0001104659-19-049385#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1515.0,"shares_display":"1,515","price_per_share":21.2433,"price_display":"21.24","price_state":"stated","total_value":32183.5995,"total_display":"32,183.60","total_whole":"32,184","shares_owned_after":4854.0,"shares_owned_after_display":"4,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-05","filed_date":"2019-09-09","scope":"insider"},{"id":8145984,"accession":"0001104659-19-045962","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-045962","line_url":"/filing/0001104659-19-045962#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.7306,"price_display":"20.73","price_state":"stated","total_value":103653.0,"total_display":"103,653.00","total_whole":"103,653","shares_owned_after":36670.0,"shares_owned_after_display":"36,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-14","scope":"insider"},{"id":8145976,"accession":"0001104659-19-045962","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-045962","line_url":"/filing/0001104659-19-045962#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10518.0,"shares_display":"10,518","price_per_share":20.4375,"price_display":"20.44","price_state":"stated","total_value":214961.625,"total_display":"214,961.62","total_whole":"214,962","shares_owned_after":36670.0,"shares_owned_after_display":"36,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-14","scope":"insider"},{"id":7888985,"accession":"0001104659-19-008851","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-008851","line_url":"/filing/0001104659-19-008851#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4868.0,"shares_display":"4,868","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":116832.0,"total_display":"116,832.00","total_whole":"116,832","shares_owned_after":35883.0,"shares_owned_after_display":"35,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-02-14","scope":"insider"},{"id":7888979,"accession":"0001104659-19-008851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-008851","line_url":"/filing/0001104659-19-008851#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":23.7,"price_display":"23.70","price_state":"stated","total_value":94800.0,"total_display":"94,800.00","total_whole":"94,800","shares_owned_after":35883.0,"shares_owned_after_display":"35,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider"},{"id":8764331,"accession":"0001104659-19-006133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-006133","line_url":"/filing/0001104659-19-006133#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11397.0,"shares_display":"11,397","price_per_share":23.1786,"price_display":"23.18","price_state":"stated","total_value":264166.5042,"total_display":"264,166.50","total_whole":"264,167","shares_owned_after":35883.0,"shares_owned_after_display":"35,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-06","scope":"insider"},{"id":7810358,"accession":"0001104659-19-003229","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-003229","line_url":"/filing/0001104659-19-003229#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":22.65,"price_display":"22.65","price_state":"stated","total_value":90600.0,"total_display":"90,600.00","total_whole":"90,600","shares_owned_after":37463.0,"shares_owned_after_display":"37,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-23","filed_date":"2019-01-24","scope":"insider"},{"id":7810352,"accession":"0001104659-19-003229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-003229","line_url":"/filing/0001104659-19-003229#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":22.35,"price_display":"22.35","price_state":"stated","total_value":67050.0,"total_display":"67,050.00","total_whole":"67,050","shares_owned_after":37463.0,"shares_owned_after_display":"37,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-22","filed_date":"2019-01-24","scope":"insider"},{"id":7912517,"accession":"0001104659-19-002152","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-002152","line_url":"/filing/0001104659-19-002152#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3175.0,"shares_display":"3,175","price_per_share":22.15,"price_display":"22.15","price_state":"stated","total_value":70326.25,"total_display":"70,326.25","total_whole":"70,326","shares_owned_after":37463.0,"shares_owned_after_display":"37,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-16","filed_date":"2019-01-16","scope":"insider"},{"id":7912508,"accession":"0001104659-19-002152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-002152","line_url":"/filing/0001104659-19-002152#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":22.15,"price_display":"22.15","price_state":"stated","total_value":177.2,"total_display":"177.20","total_whole":"177","shares_owned_after":37463.0,"shares_owned_after_display":"37,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-14","filed_date":"2019-01-16","scope":"insider"},{"id":6289053,"accession":"0001104659-18-071150","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-071150","line_url":"/filing/0001104659-18-071150","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13980.0,"shares_display":"13,980","price_per_share":21.49595207439199,"price_display":"21.50","price_state":"stated","total_value":300513.41,"total_display":"300,513.41","total_whole":"300,513","shares_owned_after":37463.0,"shares_owned_after_display":"37,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider","n_lines":2},{"id":6014511,"accession":"0001104659-18-070672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-070672","line_url":"/filing/0001104659-18-070672#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1520.0,"shares_display":"1,520","price_per_share":20.487,"price_display":"20.49","price_state":"stated","total_value":31140.24,"total_display":"31,140.24","total_whole":"31,140","shares_owned_after":8849.0,"shares_owned_after_display":"8,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-28","filed_date":"2018-11-29","scope":"insider"},{"id":6184191,"accession":"0001104659-18-069952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-069952","line_url":"/filing/0001104659-18-069952#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1299.0,"shares_display":"1,299","price_per_share":20.2577,"price_display":"20.26","price_state":"stated","total_value":26314.7523,"total_display":"26,314.75","total_whole":"26,315","shares_owned_after":37463.0,"shares_owned_after_display":"37,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-23","filed_date":"2018-11-26","scope":"insider"},{"id":6821029,"accession":"0001104659-18-067952","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-18-067952","line_url":"/filing/0001104659-18-067952#line-5","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11808.0,"shares_display":"11,808","price_per_share":21.2077,"price_display":"21.21","price_state":"stated","total_value":250420.5216,"total_display":"250,420.52","total_whole":"250,421","shares_owned_after":38762.0,"shares_owned_after_display":"38,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-13","scope":"insider"},{"id":6821020,"accession":"0001104659-18-067952","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-067952","line_url":"/filing/0001104659-18-067952#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":"0001743927","owner_name":"Liawatidewi Yakob","owner_display_name":"Liawatidewi Yakob","owner_url":"/insider/0001743927","role":"Officer (SVP Corp Admin Center)","role_mark":"O","role_mark_label":"Officer (SVP Corp Admin Center)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Corp Admin Center","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":20.5,"price_display":"20.50","price_state":"stated","total_value":123000.0,"total_display":"123,000.00","total_whole":"123,000","shares_owned_after":40763.0,"shares_owned_after_display":"40,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-08","filed_date":"2018-11-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001297184","name":"Amphastar Pharmaceuticals, Inc.","url":"/issuer/0001297184","role":"Director, Officer (EVP CORP ADMIN CENTER)","n_filings":23,"first_seen":"2018-11-13","last_seen":"2024-11-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001743927","retrieved_at":"2026-08-27T15:36:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}